{"slideshow_credits": null, "snippet": "A retired drug company executive faults the price tactics of certain companies.", "abstract": null, "section_name": "Opinion", "print_page": "20", "document_type": "article", "byline": [], "web_url": "http://www.nytimes.com/2015/10/10/opinion/time-to-import-drugs.html", "lead_paragraph": "A retired drug company executive faults the price tactics of certain companies.", "headline": {"print_headline": "Time to Import Drugs", "main": "Time to Import Drugs", "content_kicker": "Letter", "kicker": "Letter"}, "_id": "56184d9438f0d814e13703c5", "word_count": "93", "multimedia": [], "pub_date": "2015-10-10T00:00:00Z", "source": "The New York Times", "news_desk": "Letters", "keywords": [{"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "1"}, {"name": "organizations", "value": "Valeant Pharmaceuticals International Inc", "is_major": "N", "rank": "2"}, {"name": "organizations", "value": "Food and Drug Administration", "is_major": "N", "rank": "3"}], "blog": [], "subsection_name": null, "type_of_material": "Letter"}